Author

P. B. Arimondo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Ecology· 1 Pathology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Assay:DNA methylation· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Scherf· 2 shared F. Nardella· 2 shared I. Dobrescu· 2 shared L. Halby· 2 shared A. Carrier· 1 shared A. Claës· 1 shared A. Delaunay· 1 shared A. Delmas· 1 shared

Activity by Year

2022-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

A. Scherf

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Epigenetic variation causes heritable variation in complex traits in the mollusk Biomphalaria glabrata, vector of the human parasite Schistosoma mansoni

N. Luviano, M. Lopez, F. Gawehns, B. Haegeman, P. Mouginot, C. Chaparro, P. B. Arimondo, B. Pujol, D. Pouzol, C. Cosseau, C. Grunau

The paper shows that epigenetic variation in Biomphalaria glabrata affects heritable complex traits like fecundity and resistance to Schistosoma mansoni.

bioRxiv · Jul 8, 2023 · PreprintEcology

Quinazoline-quinoline bisubstrate inhibitors target eukaryotic translation initiation factor 3 in Plasmodium falciparum

I. Dobrescu, E. Hammam, J. M. Dziekan, A. Claës, L. Halby, P. Preiser, Z. Bozdech, P. B. Arimondo, A. Scherf, F. Nardella

This study identifies PfEIF3i as a target of quinoline-quinazoline inhibitors in Plasmodium falciparum, showing its essential role in parasite development and potential as an antimalarial drug target.

bioRxiv · Dec 10, 2022 · PreprintPharmacology & Toxicology

Hemisynthetic derivatives of the natural alkaloid trilobine are fast-acting antimalarial compounds with sustained activity in multi-drug resistant P. falciparum isolates

F. Nardella, I. Dobrescu, H. Hassan, F. Rodrigues, S. Thiberge, L. Mancio, A. Tafit, C. Jallet, V. Cadet-Daniel, S. Goussin, A. Lorthiois, Y. Menon, N. Molinier, D. Pechalrieu, C. Long, , P. B. Arimondo

bioRxiv · Aug 30, 2022 · PreprintPathology

DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness

A. Carrier, C. Desjobert, L. Ponger, L. Lamant, M. Bustos, J. Torres-Ferreira, R. Henrique, C. Jeronimo, L. Lanfrancone, A. Delmas, G. Favre, A. Delaunay, F. Busato, D. S. B. Hoon, J. Tost, , P. B. Arimondo

The paper identifies a DNA methylation signature associated with melanoma aggressiveness using a multi-step genomic pipeline across different host environments.

bioRxiv · Apr 11, 2022Cancer Biology